Filter
216
Filtered Results: 216
Text search:
National
Center
for
Emerging
and
Zoonotic
Infectios
Diseases
Featured
Recommendations
26
New Publications
50
Language
Document type
No document type
97
Studies & Reports
51
Guidelines
39
Strategic & Response Plan
14
Manuals
9
Fact sheets
6
Countries / Regions
Global
11
Liberia
9
Sierra Leone
8
Ethiopia
6
Rwanda
6
Africa
6
Uganda
5
Latin America and the Carribbean
5
Nigeria
4
West and Central Africa
4
India
3
Kenya
3
Guinea
2
Philippines
2
Nepal
2
Tanzania
2
South Africa
2
Bangladesh
2
East and Southern Africa
2
Congo, Democratic Republic of
1
USA
1
Zimbabwe
1
Pakistan
1
Germany
1
Zambia
1
Cambodia
1
China
1
Peru
1
Brazil
1
Botswana
1
Lesotho
1
Middle East and North Africa
1
South–East Asia Region
1
Western Pacific Region
1
Qatar
1
Vietnam
1
France
1
Authors & Publishers
Publication Years
Category
Countries
47
Clinical Guidelines
24
Public Health
13
Key Resources
13
Pharmacy & Technologies
6
Capacity Building
5
Women & Child Health
3
Toolboxes
Rapid Response
32
AMR
27
Planetary Health
27
Ebola
21
COVID-19
18
Zika
17
NTDs
14
Global Health Education
11
TB
4
Natural Hazards
3
Caregiver
3
Polio
2
Refugee
2
Specific Hazards
2
Cholera
1
HIV
1
Pharmacy
1
Health Financing Toolbox
1
Division of Global Migration and Quarantine
April 16, 2012
As the nation’s public health leader, the Centers for Disease Control and Prevention (CDC) is actively engaged in a ... effort to protect the public’s health from the harmful effects of climate change. Scientists from CDC’s National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) are at the forefront of many of these efforts. This report highlights some of that work and also looks ahead to the important work yet to come.
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes...
Bioethics 519 (online) doi:10.1111/bioe.12145 Volume 29 Number 8 2015 pp. 488–596;
Pandemic plans recommend phases of response to an emergent infectious disease (EID) outbreak, ... are primarily aimed at preventing and mitigating human-to-human transmission. These plans carry presumptive weight and are increasingly being operationalized at the national, regional and international level with the support of the World Health Organization (WHO). The conventional focus of pandemic preparedness for EIDs of zoonotic origin has been on public health and human welfare. However, thisfocus on human populations has resulted in strategically important disciplinary silos. As the risks of zoonotic diseases have implications that reach across many domains outside traditional public health, including anthropological, environmental, and veterinary fora, a more inclusive ecological perspective is paramount for an effective response to future outbreaks.
The GHS Index is intended to be a key resource in the face of increasing risks of high-consequence and globally catastrophic biological events and in light of major gaps in international financing <... preparedness. These risks are magnified by a rapidly changing and interconnected world; increasing political instability; urbanization; climate change; and rapid technology advances that make it easier, cheaper, and faster to create and engineer pathogens.
Key findings from the study of 195 countries:
• Out of a possible 100 points, the average GHS Index score across 195 countries was 40.2.
• The majority of high- and middle-income countries do not score above 50.
• Action is urgently needed to improve countries’ readiness for high-consequence infectious disease outbreaks.
PlosOne https://doi.org/10.1371/journal.pone.0161576; Zoonotic diseases have varying public health burden and socio-economic impact across time ... geographical settings making their prioritization for prevention and control important at the national level. We conducted systematic prioritization of zoonotic diseases and developed a ranked list of these diseases that would guide allocation of resources to enhance their surveillance, prevention, and control.
The Event-based Surveillance Framework is intended to be used by authorities and agencies responsible for
surveillance and response. This framewo...
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high ... access to health facilities and laboratories is difficult, antibiotics have long acted as miracle drugs. Today, however, the emergence of drug
resistance in bacteria is reversing the miracles of the past eighty years, with drug choices for the treatment of many bacterial infections becoming increasingly limited, expensive, and in some cases, nonexistent. Diseases previously regarded as relatively easy to manage are much harder to treat as doctors must use “last-resort” drugs that are more costly, take longer to work
and are often unavailable or unaffordable in developing countries. Moreover, regular prescription of antibiotics, random treatment, over the counter sales, inadequate dosage, inclusion of antibiotics in animal feeds and agriculture has contributed equally to emergence of antibiotics resistance as silent epidemic within the country.
A Global Analysis of Antimicrobial Resistance and Its Drivers.
Since the first State of the World’s Antibiotics report in 2015, antimicrobial resistance has leveled off in some high-income countries but continues to rise in many low- ... middle-income countries (LMICs), where access to antibiotics has risen with increases in gross domestic product per capita. Per capita antibiotic consumption in LMICs is lower than in high-income countries, despite a higher infectious disease burden; however, consumption rates are rapidly converging. These trends reflect both better access to antibiotics for those who need them and increases in inappropriate antibiotic use.
As the number of transboundary pest and animal and foodborne disease outbreaks rises, so does the number of people who are chronically hungry due t...
This document compiles the recommendations made by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) to help professionals in charge of vector control programs in Latin America ... the Caribbean at the national, subnational, and local level update their knowledge in order to make evidence-based decisions on the most appropriate control measures for each specific situation. IVM can be used for surveillance and control or for elimination of VBDs and can help reduce the development of insecticide resistance through the rational use of these products. This document provides instructions for fulfillment of the 2008 PAHO mandate set forth in CD 48/13 (Integrated Vector Management).
The strategic plan reflects shared commitments to enhance collaboration between environmental, animal (wildlife and domestic) and human health, and...
